Beyond the Endpoint

Smartwatches, fitness trackers, and health data—how are wearables reshaping clinical research? In this episode, Dr. Marat Fudim joins us for an insightful discussion on how wearable technology is shaping the way we monitor health and conduct research. Topics include: • Are wearables improving patient care or just tracking steps? • How do researchers use wearable data in clinical trials? •What are...

In this episode of Beyond the Endpoint, Emily O’Brien and Manesh Patel sit down with Leslie Curtis, former senior FDA policy advisor, to explore the FDA’s role in balancing science, public health, and regulation, along with how political transitions influence clinical research, healthcare funding, and the approval process for new treatments. 🔗 Access resources related to this episode https://dcri...

Reducing hypertension risk isn’t just about cutting salt. This week on Beyond The Endpoint, Emily O’Brien, Manesh Patel, and Jenny Cook talk with Dr. Dhruv Kazi about the complex public health battle against hypertension. From interventions to strategies for patient and physician adherence, this episode covers scalable solutions to change the future of hypertension. 🔗 Access resources related to...

In this episode of "Beyond the Endpoint," hosts Emily O'Brien and Manesh Patel are joined by guest host Jenny Cook to discuss grief among healthcare providers with Tony Galanos, a researcher and physician at the Duke University School of Medicine. Galanos — "Dr. G" as he's called around Duke — shares insights from his 12-year program helping other clinicians to address and process the grief that c...

Inviting Our Colleagues To Participate In DCRI On Record by Duke Clinical Research Institute

John Shepherd And Michele Nolen by Duke Clinical Research Institute

Assessing Results of Open-label, Comparative Effectiveness Trials for Cardio-metabolic Drugs by Duke Clinical Research Institute

Duke IBD Podcast Series: IBD and Nutrition by Duke Clinical Research Institute

IBD Podcast with Dr. Jane Onken by Duke Clinical Research Institute

Patient Perspective Nutrition And Diet In Perioperative Recovery by Duke Clinical Research Institute

Nutrition In ERAS: " A Call For Clinical Trials" by Duke Clinical Research Institute

Data, Innovation & Guidelines in Gastroenterology – Deborah Fisher, MD by Duke Clinical Research Institute

Sunil Rao at TCT 2018: Meeting Highlights and the #RadialFirst Journey by Duke Clinical Research Institute

Renato Lopes at TCT 2018: SECURE-PCI and Timing for Statin Dosing by Duke Clinical Research Institute

Jennifer Rymer at TCT 2018: Aborted TAVR Procedures and Same-Day Discharge for PCI by Duke Clinical Research Institute

Nutrition in Surgery – The Clinician’s Perspective by Duke Clinical Research Institute

The Role of the Dietician in Perioperative Nutrition Screening and Care by Duke Clinical Research Institute

Perioperative Nutrition Optimization Clinics: The Future of Perioperative Care by Duke Clinical Research Institute

The Role of Nutrition in 'Strong for Surgery' by Duke Clinical Research Institute

What are clinical trials? Who should participate in them? And why are they important? In this episode of Science is the Best Medicine, Abhinav Sharma talks to Harvard’s Eugene Braunwald, MD, a cardiologist who’s been a firsthand witness to more than 50 years of clinical trials.

Duke’s Mona Fiuzat, PhD, talks with Abhinav Sharma about how scientific discoveries are translated to usable treatments and how the U.S. Food and Drug Administration really works.

Cardiologist Joseph Hill, MD, PhD, editor-in-chief of Circulation, discusses what it’s like to run a peer-reviewed journal and how medical discoveries are disseminated in the age of information overload.

Medicare, Obamacare, rising costs, and preexisting conditions: The controversy over health care in the United States rages on in Congress and online. In this episode Mark McClellan, director of the Margolis Center for Health Policy and former U.S. Food and Drug Administration commissioner, discusses the complexities of healthcare policy.

Robert Lefkowitz, MD, won the Nobel Prize for Chemistry in 2012 for his groundbreaking work on the proteins known as receptors. That research has since influenced the development of a wide variety of drugs including antihistamines, ulcer drugs, and beta blockers. In this episode of the podcast, he discusses his research, his family, and the path that brought him to Duke.

Every year, more than two million people in the United States get infections that are resistant to antibiotics and at least 23,000 people die as a result, according to the Centers for Disease Control. These so-called "superbugs" represent one of the major public health threats facing the world today. In this episode, Ephraim Tsalik, MD, PhD, discusses the rise of superbugs and how researchers are...